Side-by-side comparison of AI visibility scores, market position, and capabilities
First DSPM provider to reach $100M revenue; cloud-native AI platform for data security, privacy, and compliance; $320M raised; unicorn and centaur status confirmed.
BigID is a modern data security and privacy platform founded in 2016 by Dimitri Sirota and Nimrod Vax, headquartered in New York. The company pioneered the Data Security Posture Management (DSPM) category, providing organizations with AI-powered visibility and control over their sensitive data across cloud, multi-cloud, on-premises, and hybrid environments. BigID's platform discovers, classifies, and maps sensitive data at enterprise scale — identifying personal information, regulated data (PCI, HIPAA, GDPR), intellectual property, and shadow data — and provides actionable controls for data minimization, access governance, compliance reporting, and breach response. The platform natively integrates with major cloud providers (AWS, Azure, GCP) and data repositories.
Delinea is a privileged access management platform delivering secrets management, privilege elevation, and session controls across cloud, on-premise, and hybrid environments.
Delinea is a privileged access management (PAM) company headquartered in Redwood City, California, formed in 2021 through the merger of Thycotic and Centrify — two established PAM vendors whose combination created one of the largest independent players in the privileged access security market. The merger was backed by TPG Capital and brought together Thycotic's Secret Server vault and cloud PAM capabilities with Centrify's identity-centric privileged access controls and zero trust architecture, creating a unified platform that addresses the full spectrum of PAM use cases: vaulting and rotating privileged credentials, enforcing just-in-time privilege elevation, recording and auditing privileged sessions, and managing machine and application secrets at scale.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.